OUR KEY PEOPLE

Pro-Pharmaceuticals' management team is comprised of some of the most talented and respected experts in carbohydrate chemistry, drug regulatory approval, pharmaceutical business development and finance. Empowered by decades of experience and dedication to their respective fields, our team is intent upon building a dominant position in the pharmaceutical industry by building partnerships and achieving unprecedented milestones.

 

OUR MANAGEMENT TEAM INCLUDES:

Board of Directors

Scientific Advisory Board

David Platt, Ph.D. Chairman

James C. Czirr

Burton Firtel

Dale H. Conaway M.S. D.V.M.

David H. Smith

Edgar Ben-Josef M.D.

Mildred Christian Ph.D, Fellow, ATS

David Platt, Ph.D. Chief Executive Officer

Anatole A. Klyosov, Ph.D. D.Sc.

Irwin Joseph Goldstein, Ph.D.

Henry J. Esber Ph.D.

Mildred Christian Ph.D, Fellow, ATS

Dale H. Conaway MS D.V.M.

Edgar Ben-Josef MD

Chief Operating Officer Chief Scientist
Maureen E. Foley

Anatole A. Klyosov, Ph.D. D.Sc.
Chief Financial Officer Medical Director
David A. Christopher, MBA

Marilyn C. Pike, MD, Ph.D.
Vice President, Investor Relations  
Anthony D. Squeglia, MBA